CollPlant Biotechnologies (CLGN) Change in Account Payables (2020 - 2025)
CollPlant Biotechnologies (CLGN) posted Change in Account Payables of -$8000.0 for Q4 2025, down 117.02% on a QoQ basis from $47000.0 in Q3 2025, and up 94.24% year-over-year from -$4118.5 in Q4 2024.
CollPlant Biotechnologies (CLGN) Change in Account Payables (2020 - 2025) Analysis & Trends
CollPlant Biotechnologies' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$8000.0 for Q4 2025.
- Quarterly Change in Account Payables rose 94.24% year-over-year to -$8000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$299000.0 (down 171.82% YoY) and the FY2025 annual result came in at -$260000.0, down 136.36% from the prior year.
- Change in Account Payables was -$8000.0 for Q4 2025 at CollPlant Biotechnologies, down from $47000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $253000.0 in Q4 2022 and bottomed at -$248000.0 in Q1 2023.
- A 5-year average of -$4631.6 and a median of -$8000.0 in 2025 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 695.24% in 2021, while the deepest fall reached 1881.82% in 2021.
- CollPlant Biotechnologies' Change in Account Payables stood at $169000.0 in 2021, then soared by 49.7% to $253000.0 in 2022, then declined by 6.72% to $236000.0 in 2023, then slumped by 158.9% to -$139000.0 in 2024, then soared by 94.24% to -$8000.0 in 2025.
- Business Quant data shows CLGN's Change in Account Payables at -$8000.0 in Q4 2025, $47000.0 in Q3 2025, and -$199000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | -199,000.00 |
| Jun 30, 2025 | -199,000.00 |
| Dec 31, 2024 | -139,000.00 |
| Dec 31, 2024 | -139,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 236,000.00 |
| Dec 31, 2023 | 236,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Jun 30, 2023 | -122,000.00 |
| Jun 30, 2023 | -122,000.00 |